European Spinocerebellar Ataxia Type 3/Machado*Joseph Disease Initiative

European Spinocerebellar Ataxia Type 3/Machado*Joseph Disease Initiative - ESMI

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55616

Enrollment

Registered

2017-03-23

Start date

2017-05-01

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebellar dysfunction disorder of coordination

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients and carriers with SCA3 18 and older

Exclusion criteria

Exclusion criteria: Other neurological disorders Claustrofobia Metal prosthesis or other metal objects in body Implanted electronic devices such as a pacemaker

Design outcomes

Primary

Measure	Time frame
Main study parameters/endpoints: A large cohort of preclinical and mildly ataxic SCA3 mutation carriers, which includes a model of disease evolution in SCA3 and new clinical, motor, imaging and biochemical markers.	—

Countries

Netherlands

Outcome results